In this episode, Dr. Kumar talks about the insidious nature of ageism and how rheumatologists can combat it.
New Guidance on Mental Health Screening in Pediatric Rheumatology
Pediatric rheumatologic diseases are characterized by high rates of anxiety & depression known to impact health-related outcomes. CARRA and the ACR developed guidance statements to assess & manage mental health concerns for youths in pediatric rheumatology practice.
Rheuminations: Ageism Is a Threat to Quality Care
Learn how to identify & combat age-based discrimination for improved communication & better patient outcomes.
President’s Corner: Partners in Care & Research, the ARP & Rheumatology Research Foundation
The ARP & the Rheumatology Research Foundation are key partners in advancing rheumatology. Learn how they support care, training & research on their anniversaries.
Doctoring Differently, Part 1
Dr. Samantha Shapiro recounts her enthusiastic and ambitious early career in rheumatology—a path that culminated in burnout and a brave choice with new opportunities.
Study: Are TNF Inhibitors Safe for Patients with RA-ILD?
Despite anecdotal reports to the contrary, a large observational study concludes that TNF inhibitors, compared with non-TNF biological or targeted synthetic DMARDs, do not cause higher rates of death or respiratory hospitalization in patients with RA-ILD.
Tips for Starting Your Own Rheumatology Practice
Dr. Anna Zezon discusses the challenges, opportunities & joys of running a private rheumatology practice as a solo practitioner.
Insights from an Orthopedic Spine Surgeon
Dr. Jay Reidler, an adult & pediatric orthopedic spine surgeon, shares insights from his field & discusses his collaborations with rheumatologists.
What Rheumatologists Should Know About B Cell Tolerance & Autoimmunity
A recent Arthritis & Rheumatology review article explores the immune system’s mechanism for creating B cells that respond to diverse pathogens while preserving immune tolerance & highlights key insights for rheumatologists.
Rheumatology Celebrates Key Milestones
The Association for Rheumatology Professionals (ARP) celebrates 60 years & the Rheumatology Research Foundation marks 40 years of advancing patient care & research.
Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis Released
New global criteria for pediatric CNO aim to boost research & improve care for this rare autoinflammatory bone disease.
Cancer & RA Drugs: Are Some Drugs Riskier than Others?
Sendaydiego et al. asked: Do some DMARDs pose a greater cancer risk than others for patients with RA? Here are insights from the study and its clinical implications.
Insights into Mechanisms of Anti-Inflammatory Response to Exercise
A recent Proceedings of the National Academy of Sciences study found that high-intensity aerobic exercise may reduce the release of cell-free DNA & tamp down inflammation over time.
What Clinicians Should Know About Midfoot Osteoarthritis
Midfoot OA experts offer an overview of a common, but under-recognized, form of OA, & discuss quality of life impacts, treatments, clinical evaluation procedures & the critical need for further research.
Study: Reducing Cardiovascular Risks Helps Lupus Patients
Long-term remission & control of CVD risk factors can reduce the risk of atherosclerosis in lupus; triple APL positivity raises the risk of CVD, study finds.
ACR Advocates for Fair Reimbursement & Telehealth Flexibility in MPFS 2026 Proposed Rule
In comments to the CMS, the ACR advocated for telehealth flexibilities and fair reimbursement and pushed back on proposed efficiency adjustments and changes likely to increase administrative burden on practices.
AMA State Advocacy Roundtable Addresses Pressing Policy Challenges
The roundtable included discussions on emerging issues in state advocacy, prior authorization reform, likely impacts of the Big Beautiful Bill and physician wellness.
Cardiovascular Risks Similar for JAK Inhibitors & bDMARDs
Using data from registries across Europe and Canada, Aymon et al. compared the incidence of major adverse cardiac events (MACE) in patients with RA treated with JAK inhibitors, TNF inhibitors or biologic DMARDs with other modes of action over two years. The researchers did not find an increased risk of MACE with JAK inhibitors over that time frame.
Why Advocacy Matters: A Call to Action for Rheumatologists
In today’s rapidly evolving healthcare landscape, rheumatologists face a growing number of challenges. Advocacy is a critical tool that helps protect and advance the profession and the patients it serves.
Results for Novel, Glucocorticoid-Sparing Treatment for Patients with PMR
A phase 2 study from Spiera et al. found that patients with glucocorticoid-dependent PMR taking the antibody-drug conjugate ABBV-154 had a longer time to flare compared with those taking placebo, supporting further investigation.
Rheumatology Influencers: Dr. Hirsh Advocates for Physicians & Patients
Dr. Marc Hirsch reflects on a career dedicated to advocating for physicians, providing patient-centered care & advancing medical education.
A New Treatment for Fibromyalgia?
The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.